Preclinical CAR-T testing in ALL
Strengthen efficacy and safety evidence using relevant preclinical models and translational data.
Offer overview
What this offer helps you achieve
Strengthen efficacy and safety evidence using relevant preclinical models and translational data.
Scientific and technical scope
Preclinical testing of CAR-T cells for the treatment of T/B acute lymphoblastic leukemia (ALL): Preclinical testing the efficacy of CAR-T-cell therapy in ALL, to assess the impact of CAR-T-cells on leukemia cells and lymphocyte development. Availability of PDX models derived from patients with T/B-ALL (pediatric)
Capabilities mobilised
Therapeutic areasValidation using preclinical models
Application fields
Oncology
Discuss this offer
Could this capability strengthen your R&D programme?
Present your scientific, technical or clinical need and identify the most relevant route to collaboration.
Continue exploring
Related expertise for your programme
Offers selected through shared capabilities, application fields or institute expertise.
